| Christopher George Whitehead, RPH | |
|
1 Va Ctr, Augusta, ME 04330-6719 | |
| (207) 623-8411 | |
| Not Available |
| Full Name | Christopher George Whitehead |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1 Va Ctr, Augusta, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306937321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 25506 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher George Whitehead, RPH 92 Green St, Augusta, ME 04330-5407 Ph: (207) 512-2833 | Christopher George Whitehead, RPH 1 Va Ctr, Augusta, ME 04330-6719 Ph: (207) 623-8411 |
News Archive
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease (COVID-19), an illness that has spread across the globe, infecting more than 9 million people. The novel coronavirus invades cells through "spike proteins," which sticks and binds itself to a host cell.
Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.
Oral malodor in patients with periodontitis is better treated by periodontal treatment than tongue cleaning, but both treatments are necessary to effectively remove the disease, contend the authors of a study review.
NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology and cancer supportive care,announced preliminary revenue results for fourth quarter 2011 and full year 2011. Fourth quarter MuGard product sales increased 400% over third quarter product sales.
› Verified 4 days ago
Mrs. Kimberly A Townsend, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Western Ave, Augusta, ME 04330 Phone: 207-626-0364 Fax: 207-626-0470 | |
Dr. Rachel Ann Mayer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Christopher F Parsons, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Dr. Cassandra Rose White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Dr. Jody K Kundreskas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Kaitlin Elizabeth Murphy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2007 N Belfast Ave, Augusta, ME 04330 Phone: 207-622-2626 | |
Dr. Amber Lynn Tardiff, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24 Stone St, Augusta, ME 04330 Phone: 207-623-4181 Fax: 207-622-0760 |